Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04569500

FRENCH THERAPEUTIC EDUCATION PROGRAM AIMING TO IMPROVE LARYNGECTOMIZED PATIENTS' AND THEIR FAMILY CAREGIVER'S QUALITY OF LIFE

The therapeutic education of patients and their close relations is, as yet, poorly developed in France in the field of oncology (Pérol2007), in particular for cancers of the upper aerodigestive tract (Allison2010). In the case of pharyngeal and laryngeal cancer, total laryngectomy associated with radiotherapy remains a reference treatment for advanced stage cancers. This mutilating surgical procedure has a major impact on the patient's life, due to its physical and functional sequelae: phonatory (loss of physiological voice), feeding, olfactory and aesthetic (tracheostomy). Its psychosocial consequences are also important, owing to the biographical disruption and the identity-related metamorphoses associated with illness and its treatment, which alter the quality of life not only of patients, but also of their close relations. Indeed, transformation is not only at individual level, it also impacts the life of close relations, in particular spouses, who share the day-to-day lives of patients (Babin 2010). Currently, care for laryngectomized patients consist essentially in informing and educating them on certain technical procedures (cannula replacement, mucosity aspiration, tracheostomy or phonatory implant cleaning) during hospital admission. Such education may be formalized and dispensed within the context of a therapeutic education program.

The issue of this study will be to determine what therapeutic education program we should offer patients and their close relations in order to accompany them throughout their experience of laryngectomy and to reduce its impact on social and professional aspects of life.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU Caen

Caen, France

Location status: Recruiting

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Patient inclusion criteria

  • Patients over 18 having been treated by total laryngectomy for cancer of the larynx, pharynx or cervical esophagus.
  • Patients accepting to participate in the study (informed consent form explained and signed).
  • Patient having not been undergone a PTE
  • Person affiliated with an appropriate social security system.

Close relation inclusion criteria

  • Person over 18 designated as being a close relation by the laryngectomized patient (confidential person, spouse, parent, natural support person or any person whose quality of life may be impacted by the patient's laryngectomy).
  • Close relation accepting to participate in the study (informed consent form explained and signed).
  • Person authorized by the patient to be contacted by the investigator, in order to propose his/her participation in the research study.
  • Person affiliated with an appropriate social security system.

Patient exclusion criteria - Physical, psychical, psychiatric or cognitive incapacity to answer to questions or participate in interviews/sessions.

Close relation exclusion criteria

  • Physical, psychical, psychiatric or cognitive incapacity to answer to questions or participate in interviews/sessions.

Treatment and study plan

PETAL program

Other

patients and their close relations will benefit from the therapeutic education program PETAL in order to accompany them throughout their experience of laryngectomy and to reduce its impact on social and professional aspects of life.

Primary outcomes

  1. Quality of life score (PSS-HN scale) of patients with total laryngectomy

    Time frame: 12 months

    Difference in gain observed at six months in the mean quality of life score (PSS-HN scale) of patients with total laryngectomy and their close relatives, having benefited from the PTE program and those having benefited from usual care.

Secondary outcomes

  1. Quality of life score (EVA scale) of patient's close relatives

    Time frame: 12 months

    difference in gain observed at six months in the mean quality of life score (EVA scale) between close relations having benefited from the PTE program and those having benefited from usual support.

Study contacts

Contact information is provided by the study sponsor or research team.

Emmanuel PH BABIN

CONTACT

[email protected]

+33231064866

François FOURNEL

CONTACT

[email protected]

+33231065488

Sponsors and collaborators

Lead sponsor

University Hospital, Caen

Other

Registry information

Acronym: PETAL2

Important dates

Study start
2021
Primary completion
2026
Study completion
2027
First posted
Sep 30, 2020
Registry last updated
Jul 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.